184 related articles for article (PubMed ID: 14665448)
21. Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome.
Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S233-7. PubMed ID: 17606307
[TBL] [Abstract][Full Text] [Related]
22. [Leptin in patients with polycystic ovary syndrome. Direct correlation with insulin resistance].
Calvar CE; Intebi AD; Bengolea SV; Hermes R; Spinedi E
Medicina (B Aires); 2003; 63(6):704-10. PubMed ID: 14719312
[TBL] [Abstract][Full Text] [Related]
23. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
24. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome.
Fulghesu AM; Angioni S; Portoghese E; Milano F; Batetta B; Paoletti AM; Melis GB
Fertil Steril; 2006 Aug; 86(2):398-404. PubMed ID: 16769061
[TBL] [Abstract][Full Text] [Related]
25. beta-Cell function and insulin sensitivity in adolescents from an OGTT.
Sunehag AL; Man CD; Toffolo G; Haymond MW; Bier DM; Cobelli C
Obesity (Silver Spring); 2009 Feb; 17(2):233-9. PubMed ID: 19057529
[TBL] [Abstract][Full Text] [Related]
26. Influence of hypo- and hyperglycaemia on plasma leptin concentrations in healthy women and in women with polycystic ovary syndrome.
Ludwig AK; Weiss JM; Tauchert S; Dietze T; Rudolf S; Diedrich K; Peters A; Oltmanns KM
Hum Reprod; 2007 Jun; 22(6):1555-61. PubMed ID: 17395684
[TBL] [Abstract][Full Text] [Related]
27. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
[TBL] [Abstract][Full Text] [Related]
28. Increased secretion of amylin in women with polycystic ovary syndrome.
James S; Moralez J; Nagamani M
Fertil Steril; 2010 Jun; 94(1):211-5. PubMed ID: 19338997
[TBL] [Abstract][Full Text] [Related]
29. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
Kurioka H; Takahashi K; Miyazaki K
Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
[TBL] [Abstract][Full Text] [Related]
30. Genetic determinants of insulin action in polycystic ovary syndrome.
Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113
[TBL] [Abstract][Full Text] [Related]
31. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
32. The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome.
Noyan V; Yucel A; Sagsoz N
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):200-5. PubMed ID: 15262356
[TBL] [Abstract][Full Text] [Related]
33. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
34. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
Alvestrand A; Mujagic M; Wajngot A; Efendic S
Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
[TBL] [Abstract][Full Text] [Related]
35. The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome.
Angioni S; Sanna S; Magnini R; Melis GB; Fulghesu AM
Gynecol Endocrinol; 2011 Jul; 27(7):468-74. PubMed ID: 20540677
[TBL] [Abstract][Full Text] [Related]
36. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
[TBL] [Abstract][Full Text] [Related]
37. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
[TBL] [Abstract][Full Text] [Related]
38. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
39. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
40. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
Legro RS; Finegood D; Dunaif A
J Clin Endocrinol Metab; 1998 Aug; 83(8):2694-8. PubMed ID: 9709933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
